Risk Factors Associated With Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in a Cohort of 2.3 Million Israeli Adolescents

International Journal of Cancer- United States

doi 10.1002/ijc.31589

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Circulating Markers in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

2012Dutch

Comprehensive Genomic Profiling of 724 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Current Treatment Strategies for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Surgery
Surgery
2017English

Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient–Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context

Advances in Therapy
MedicinePharmacology
2018English

Neuroendocrine Neoplasms: A Brief Overview Emphasizing Gastroenteropancreatic Tumors

Autopsy and Case Reports
2017English

Body Mass Index and Kidney Disease-Related Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

Resistance to Targeted Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy